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Lectin-like oxidized low-density lipoprotein (LDL) receptor
(LOX-1)-mediated pathway and vascular oxidative injury in
older-age rat renal transplants.
Background. Older-age renal allografts are associated with
inferior survival; however, the mechanisms are unclear. Reac-
tive oxygen species participate in aging and in chronic vascular
disease. We investigated how mediators of oxidative stress may
increase allograft susceptibility to vascular injury.
Methods. We employed the low-responder allogeneic F344-
to-Lew rat renal transplantation model. We used nonimmuno-
suppressed young (donors and recipients aged 12 weeks), old
(donors and recipients aged 52 weeks), and old-to-young animal
(donors aged 52 weeks and recipients aged 12 weeks) combi-
nations. Grafts were transplanted after 2 hours cold preserva-
tion in University of Wisconsin solution and harvested 1, 2, 7
and 10 days later. Additionally, old animals receiving continu-
ous 1.5 mg/kg cyclosporine (CyA) immunosuppression were in-
cluded. Renal allograft pathology was scored according to Banff
criteria. We studied intragraft vascular adhesion molecule-1
(VCAM-1), lectin-like oxidized low-density lipoprotein (LDL)
receptor-1 (LOX-1), and hypochlorite-modified LDL expres-
sion as well as ED-1+ monocytes/macrophages and CD8+
lymphocyte infiltration. Intragraft in situ superoxide anion rad-
ical production was determined with dihydroethidium assay on
cryosections.
Results. During the first 2 posttransplant days, old trans-
plants demonstrated higher functional impairment and in-
creased oxidative stress, while young transplant had higher
ED-1+ monocytes/macrophage infiltration and VCAM-1 ex-
pression. The degree of VCAM-1 expression and ED-1+ mono-
cytes/macrophage and CD8+ lymphocyte infiltration correlated
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at later time points directly with the transplant age. VCAM-1
and LOX-1 staining were localized predominantly on the en-
dothelium of arterial vessels, shifting the distribution to vascu-
lar smooth muscle layer strongly dependent on donor age and
the grade of vascular injury. LOX-1 staining colocalized with
hypochlorite-modified epitopes in the media of injured arteries.
We measured increased in situ superoxide anion radical produc-
tion in corresponding areas. Immunosuppression with CyA had
no protective effect on vascular injury and LOX-1 expression.
Conclusion. Induction of LOX-1–related oxidation pathways
and increased susceptibility to oxidative stress could play an im-
portant role in promoting vascular injury in old renal transplants
independent of the recipient age.
Patients aged >60 years represent the largest and
fastest growing proportion of the end-stage renal disease
(ESRD) population [1, 2]. Although elderly patients ben-
efit from transplantation [3], their short- and long-term
outcomes are worse for unclear reasons. Initial lower re-
nal functional reserve or limited regeneration capacities
are potential reasons why older age may predispose to
an increased allograft loss [4]. Normal aging is associated
with increased oxidant production and a decreased an-
tioxidative defense [5]. Atherosclerosis pathways are in-
volved in coronary transplant vasculopathy and possibly
renal transplant vascular disease [6]. Lipoprotein oxida-
tive modification, particularly of low-density lipoprotein
(LDL), is a key atherogenic mechanism [7]. Endothelial
cell activation by oxidative enzymes and oxidized LDL
uptake initiates infiltration of monocytes/macrophages
and triggers inflammatory pathways within the vascular
wall [8]. Endothelial cells endocytose oxidized LDL via
LOX-1, a transmembrane lectin-like oxidized LDL re-
ceptor distinct from type I and II scavenger receptors
[9]. Activated neutrophils and monocytes/macrophages
produce hypochlorous acid/hypochlorite (HOCl) from
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hydrogen peroxide (H2O2) and chloride via myeloperox-
idase (MPO) that can convert lipoproteins into athero-
genic forms [10]. As HOCl-modified lipoproteins may
serve as ligands for LOX-1 [11], the interaction of
HOCl-LDL with LOX-1 is associated with endothelial
dysfunction [12]. We hypothesized that renal allograft mi-
crocompartment injury patterns might be age related. We
reasoned that if increased oxidative stress in aged animals
contributes significantly to transplant injury, we would
anticipate increased expression of LOX-1 and greater
LDL oxidation within the vascular wall that would ini-
tiate injurious inflammatory responses. To study age-
dependent renal transplant vascular lesion, we measured
in situ superoxide anion radical production, expression
of LOX-1, HOCl-modified lipoproteins, VCAM-1, and
infiltration with effector cells. We also studied renal allo-
graft pathology according to Banff criteria and measured
renal function in a low-responder allogeneic F344-to-Lew
rat functional model of renal transplantation of different
donor and recipient ages.
METHODS
Animals and transplantation surgery
Inbred male Fischer (F344) and Lewis (Lew, RT1) rats
of 10 and 52 weeks of age were purchased from Harlan-
Winkelman (Sulzbach, Federal Republic of Germany).
The animals had free access to tap water and a standard
rat diet (No. C-1000) (Altromin, Lage, Federal Repub-
lic of Germany). They were kept under regular lighting
conditions (lights on at 6:00: a.m. and off at 6:00 p.m.)
at a constant temperature 24◦C. Local authorities ap-
proved all experimental procedures according to Ameri-
can Physiological Society guidelines. The rats were fasted
overnight before surgery. In the “young” group, kid-
neys of 10-week-old F344 rats were transplanted into
10-week-old Lewis recipients. In the “old” group both
the F344 donors and the Lew recipients were 52 weeks
of age. Finally, in the “old-to-young” group, 52-week-old
F344 donors and 12-week-old Lew recipients were com-
bined. Donor animals were prepared as previously de-
scribed [17]. In situ perfusion with 5 mL cold University
of Wisconsin (UW) solution through cannulated aorta,
followed. Finally, the kidney was placed in cold UW so-
lution (0 to 4◦C) for 2 hours. Recipient Lew rats were
anesthetized with isoflurane and left native kidney was
removed. Vessel and the ureter anastamoses were per-
formed end-to-end using 10-0 Prolene. The anastomo-
sis time averaged 30 minutes. Upon the completion of
anastomoses, the right native kidney was removed. Both
native kidneys were preserved for later use as baseline
age-related controls. One group of four old recipient
animals received 1.5 mg/kg continuous cyclosporine A
(CyA) subcutaneously for 7 days beginning with the day
of transplantation. All other animals received no im-
munosuppression or any other medication during the
study. Venous blood was obtained from the retro-orbital
plexus for serum creatinine and urea concentrations de-
termined with automated methods. For creatinine clear-
ance measurements, a 24-hour urine was collected from
each donor and recipient studied using metabolic cages.
Arterial systolic pressure was measured in both donors
and recipients before transplantation and in recipients at
the end of the experiment by tail-cuff plethysmography.
Grafts were harvested 1, 2, 7, and 10 days after transplan-
tation (4 to 5 per time point). After harvest, grafts were
quickly dissected; one half was fresh frozen, the other
fixed in antioxidative formaldehyde/sucrose fixative [4%
paraformaldehyde, 15% sucrose, 1 mmol/L ethylenedi-
aminetetraacetic acid (EDTA), and 50 lmol/L butylated
hydroxytoluine (BHT), pH 7.4] for 12 hours at 4◦C.
Renal pathology and immunohistochemistry
Paraffin serial sections (2 lm thick) were rehy-
drated and stained by hematoxylin and eosin, Masson-
Goldner-trichrome, periodic acid-Schiff (PAS), and Jones
methenamine silver for allograft pathology scoring ac-
cording to Banff 97 criteria and vascular pathology
updates [13, 14]. Immunohistochemical stainings were
performed with the following mouse monoclonal primary
antibodies: ED-1 for monocyte/macrophages, CD8+
lymphocytes (Serotec, Oxford, UK), antirat LOX-1 (gift
from Dr. Sawamura), vascular cell adhesion molecule-1
(VCAM-1) (CD106, clone 51-1069) (Becton-Dickinson,
San Diego, CA, USA). HOCl-modified lipoproteins were
detected with monoclonal antibodies with clone 2D10G9
[15] or clone 6E10E11 [16]. Sections were deparaffinized
and rehydrated through xylene (2 × 10 minutes), 100%
ethanol (2 × 10 minutes), 95%, 70%, and 50% ethanol
and phosphate-buffered saline (PBS) (each 1 × 5 min-
utes). Antigen retrieval was induced by citrate boiling in
a pressure device for 3 minutes. To block endogeneous
peroxidase, sections were immersed in 0.3% H2O2 for
20 minutes. Next, incubation with CAS solution (Zymed,
San Francisco, CA, USA) was carried out for 30 min-
utes to block unspecific antibody binding. Incubation
with primary antibodies diluted in PBS (pH 7.6) for
1 hour followed. Sections were then rinsed twice with
PBS. Visualization was performed using the horseradish
peroxidase–labeled secondary antibody for 30 minutes
and diaminobenzidine (DAB) or amino ethyl carbazole
color detection (Dako, Glostrup, Denmark).
Acetone-fixed frozen sections were used to study
VCAM-1 expression as we previously described [17].
The immunoreactivity was visualized with an alka-
line phosphatase antialkaline phosphatase (APAAP)
complex (Dako). For detection and development, we
used neufuchsin-naphthol-AS-Bi-phosphate substrate
(Merck, Darmstadt, Federal Republic of Germany).
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Negative control stainings were performed by incubation
with corresponding isotype controls instead of primary
antibody or by preabsorption of monoclonal antibodies
(clone 2D10G9 and 6E10E11) with HOCl-LDL as de-
scribed [15].
Detection of in situ reactive oxygen species production
In situ superoxide anion production was determined
by dehydroethidium (DHE) labeling as described [18].
In the presence of superoxide anion radical, DHE is
converted to the fluorescent molecule ethidium that is
capable of labeling nuclei by intercalating with DNA.
Briefly, 15 lm thick frozen sections were incubated with
10 lmol/L DHE (Molecular Probes, Eugene, OR, USA)
for 15 minutes at 37◦C in a light-protected humidified
chamber, rinsed in PBS, mounted and analyzed by using
a fluorescent microscope. Quantitative analysis was car-
ried out on binarized pictures applying the same thresh-
old level for all sections. Only bright fluorescing nuclei
were considered positive. Number of total nuclei were
counted after 4’,6 diamino-2-phenylindole (DAPI) ap-
plication (Vector Laboratories, Birmingham, AL, USA)
and value calculated as percentage of positive from total
nuclei per arterial cross section.
Morphometry and statistics
Two independent investigators (J.H.B. and M.N.K.)
conducted the morphometric analysis in a blinded fash-
ion. The degree of ED-1–positive macrophage and
CD8+ lymphocyte cell infiltration was determined using
a computer-assisted morphometry unit (Zeiss/Kontron,
Go¨ttingen, Germany). The positively immunostained
area was binarized and calculated as a percent of a to-
tal cross sectional area in renal cortex and inner stripe of
outer medulla (values represent means of data pooled for
each group calculated from five measurements per area
and animal). Expression of VCAM-1 and LOX-1 was
analyzed using a semiquantitative grading system where
positive arteries were calculated as percent of total ar-
teries per cross section. The results between groups were
compared using nonparametric Mann-Whitney U test. A
P value <0.05 was considered significant.
RESULTS
We first studied creatinine clearance in age-matched
recipients of young and old renal transplants during the
first 2 posttransplant days to investigate vulnerability to
ischemia/reperfusion (I/R) injury. Potential strain or age-
related effects on renal function were excluded before
transplantation as there was no age-dependent difference
in creatinine clearances in both F344 donor (young 1.30 ±
0.12 mL/min vs. old 1.35 ± 0.22 mL/min) and Lew re-
cipient animals (1.28 ± 0.14 mL/min vs. old 1.32 ± 0.18
mL/min). Already at day 1 posttransplant, old renal
transplants showed more pronounced impairment in re-
nal function (old 0.40 ± 0.11 mL/min vs. young 0.68 ±
0.14 mL/min) that reached statistical significance (P ≤
0.05) at day 2 posttransplant. The values were old 0.36 ±
0.16 mL/min vs. young 0.80 ± 0.14 mL/min (Fig. 1A).
To investigate how age may influence inflammatory re-
sponses during reperfusion injury, we quantified the ED-
1+ monocytes in the experimental groups. As depicted in
Figure 1B there was no difference in cortical or medullary
ED-1+ infiltration at day 1. At day 2 posttransplant we
observed significantly more ED-1+ cells in the medulla,
but not cortex of young allografts. VCAM-1 is an en-
dothelial adhesion molecule that predominantly medi-
ates monocyte infiltration. Expression of VCAM-1 was
in parallel with monocyte infiltration. At day 2 com-
pared to old allografts significantly more arteries in young
allografts expressed VCAM-1 (Fig. 1C). To determine
whether increased inflammation may trigger oxidative
stress, we analyzed in situ superoxide anion radical pro-
duction using the DHE assay in fresh-frozen sections
from young and old renal allografts. Pretransplant basal
DHE fluorescence levels were at a similar low level
in native contralateral kidneys of both old and young
donor and recipient animals (Fig. 1D). We obtained a
significantly increased DHE fluorescence postischemia
implicating in situ superoxide anion production in old al-
lografts despite lower inflammatory response (Fig. 1D).
Later after the postischemic recovery at day 7, post-
transplant young group showed increasingly better cre-
atinine clearance at 1.21 ± 0.15 mL/min, while young
and old recipients of old allografts had numerically de-
creased values 0.92 ± 0.17 mL/min (old-old) and 1.0 ±
0.18 mL/min (old-young) that did not reach statistical sig-
nificance (Fig. 2). Renal function remained stable in the
young group at day 10 posttransplant 1.36 ± 0.20 mL/min.
In comparison, recipients of old allografts developed fur-
ther decline in creatinine clearance values 0.64 ± 0.14
mL/min (old-old) and 0.80 ± 0.16 mL/min (old-young)
at day 10 posttransplant (P ≤ 0.05 in old-old). We were
also able to exclude increased blood pressure as a pos-
sible confounder of transplant vascular injury, as there
was no difference in pretransplant blood pressure read-
ings (young 100 ± 10 vs. old 100 ± 15 mm Hg systolic)
(N = 4/group), and both young and old animals remained
normotensive during the study (young 90 ± 15 vs. old
85 ± 10 mm Hg systolic) (N = 4/group).
Renal allograft pathology scoring according to Banff
classification is summarized in Table 1. The most promi-
nent finding was an increase in severity of vascular
lesions in old allografts no matter whether they were
transplanted to young or old recipients (v2-3), charac-
teristic for Banff IIB and III rejection. There was no
difference in the extent of total interstitial infiltration
between all groups studied (i2-2.5). We observed only
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Fig. 1. Influence of ischemia/reperfusion injury on renal function, ED-1+ macrophage infiltration, vascular cell adhesion molecule-1 (VCAM-1)
expression and in situ superoxide anion production 1 and 2 days posttransplant in young-young (Y-Y) and old-old (O-O) donor, and recipient
combinations. No difference in renal function between Fischer (F344) donors and Lewis (Lew) recipients of different ages and detrimental impact
of age on renal function postischemia (A). Percentage of ED-1+ immunostained area in cortex and medulla reveals decreased ED-1+ infiltrates
in the medulla of old allografts (B). Lower number of VCAM-1–positive arteries in old allografts (C). No difference in dehydroethidium (DHE)
fluorescence in native nephrectomies and increased number of DHE-positive fluorescent nuclei in old versus young (D). All results are expressed
as means ±SD. ∗P ≤ 0.05; ∗∗P ≤ 0.005 versus young transplants (N = 5/time point).
occasional invasion of tubules with mononuclear cells in
young allografts, and there were no morphologic changes
compatible either with sublethal or lethal injury of tubu-
lar epithelial cells. To better characterize the intersti-
tial and intravascular mononuclear cell infiltrates, we
performed immunohistochemical stainings for ED-1+
monocytes/macrophages and CD8+ effector T cells. Al-
though ED-1+ cells comprised predominant marginating
and infiltrating cell population, compared to the results
obtained during postreperfusion inflammation, the anal-
ysis of kinetics and topography revealed different pattern
in age-related heterogeneity in magnitude and distribu-
tion of ED-1+ infiltrates. As shown in Figure 3A in con-
trast to the postreperfusion phase, the amount of ED-1+
cells increased more rapidly in both cortex and medulla of
old allografts independent of recipient age, whereas the
most prominent ED-1+ infiltration was observed in their
medullary interstitium. In contrast, analysis of CD8+
T-cell interstitial infiltrates revealed numerically more
pronounced increase from day 7 to day 10 posttrans-
plant in young recipients of both young and old allografts
(Fig. 3B).
Next, we focused on the analysis of renal transplant
vasculature. Vascular changes in young animals at day
7 posttransplant involved activated endothelial cells of
cortical arteries (Fig. 4A) and vacuolization of vascular
smooth muscle cells. At the same time arteries in old al-
lografts transplanted to age-matched or mismatched re-
cipient animals showed endothelial activation, margina-
tion, adhesion and focal subendothelial mononuclear cell
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Fig. 2. Renal function (creatinine clearance) is shown for young and
old rats 7 and 10 days after transplantation. Means ±SD. ∗P ≤ 0.05
versus young transplants (N = 5/time point).
infiltration with parallel vacuolization of vascular smooth
muscle cells (Fig. 4C and E). Continuous CyA treatment
had no effect on subendothelial mononuclear infiltrates
in old allografts at day 7 posttransplant (Fig. 7A). Anal-
ysis of subendothelial infiltrate revealed that monocytes
were present in 33% and CD8+ T cells in only 1% of
arteries in old allografts (Fig. 3C and D). Similar changes
occurred in delayed manner, at day 10 posttransplant in
young allografts (Fig. 3C and D) although without rele-
vant subendothelial mononuclear cell infiltration (10%
of all arteries were positive for ED-1+ and 1% for CD8).
In contrast, vascular lesions became more severe in old
allografts independent of recipient age and were predom-
inantly characterized with transmural mononuclear in-
filtrates, a hallmark of endarteritis (Fig. 4D and F) and
focal fibrinoid necrosis of the media in old-old combina-
tion (Fig. 4D, arrow). Accordingly, the number of arteries
positive for ED-1+ monocytes/macrophages and CD8+
T cells significantly increased (Fig. 3D and E). The more
severe acute vascular injury in recipients of old kidneys
may offer an explanation for deterioration in renal func-
tion compared to recipients of young kidneys. Hence, we
focused on candidates responsible for the initiation and
amplification of the acute vascular injury in old allografts.
As the interaction of VCAM-1 with monocyte/
macrophages is essential for infiltration of the injured ar-
terial wall and later neointima formation during athero-
genesis [19], we reasoned that similar events could occur
during the acute renal transplant vascular injury. At day
7 posttransplant, we observed a strong linear VCAM-1
staining restricted to endothelial layer of arterial vessels
in both transplanted groups (not shown). Although we
were not able to see any difference in the intensity or dis-
tribution of the VCAM-1 staining, there were increased
positively stained arteries in old group at day 7 (Fig. 3E).
At day 10, in accord to the increased severity of the vas-
cular damage in old transplants, VCAM-1 appeared to be
expressed by vascular smooth muscle cells, while in young
transplants VCAM-1 expression remained restricted to
the endothelial layer. At that time point all arteries from
all groups expressed VCAM-1 (Fig. 3E).
We next studied whether or not increased expression of
LOX-1 and enhanced HOCl modification of lipoproteins
may be involved during the initiation of transplant vas-
cular injury. We observed at day 7 posttransplant LOX-
1–positive arterial intimal endothelial staining in 71%
of arteries in young renal allografts (Fig. 5A). In con-
trast, intima of all arteries in old allografts independent
of recipient age showed strong positive linear LOX-1
staining (Fig. 5A). At day 10 posttransplant nearly all
arteries (96%) in young allografts stained positive for
LOX-1 (Fig. 5A), although the expression remained re-
stricted to endothelial cell layer (Fig. 5B). The staining
intensity and distribution of LOX-1 in old allografts
paralleled VCAM-1 expression and affected vascular
smooth muscle cells of large and small arteries and ar-
terioles at day 10 (Fig. 5C and D). Additionally, infiltrat-
ing leukocytes, arterioles, and peritubular capillaries were
stained with LOX-1 antibody in old animals. LOX-1 stain-
ing (Fig. 6A) colocalized in serial sections with HOCl-
modified epitopes/lipoproteins in the media of injured
arteries of old animals (Fig. 6B). Omission of the mon-
oclonal antibodies (2D10G9 or 6E10E11) or preabsorb-
tion of both monoclonal antibodies with HOCl-LDL (at
molar ratios of 1/20) prevented antibody binding, demon-
strating that the staining was specific for HOCl-modified
epitopes generated in vivo by the MPO-H2O2-chloride
system. Continuous treatment of old animals with CyA
had no effect on LOX-1 (Fig. 7B and C) expression as
documented at day 7 posttransplant.
Arteries from old allografts independent of recipi-
ent age (Fig. 8C and D) had consistently increased nu-
clear DHE fluorescence compared to young allografts
(Fig. 8B) that was statistically significant at day 7 and day
10 posttransplant, as confirmed by quantitative analysis
(Fig. 8A).
DISCUSSION
The major finding in our study was a striking age-
related difference in the renal allograft response to vas-
cular and tubulointerstitial injury. Old allografts showed
higher functional impairment and increased oxidative
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Table 1. Allograft pathology scoring according to Banff criteria including vascular and interstitial scores and inflammatory infiltrates in cortex
and medulla of age-matched and age-mismatched transplants
Young Old Old-young
day 7 day 10 CyA day 7 day 7 day 10 day 7 day 10
Banff class IIA IIA IIA IIB III III III
Vascular 1 1 1 2 3 3 3
Interstitial 2 2 2 2 2.5 2.5 3
CyA is cyclosporine A.
stress postischemia despite lower inflammatory response.
Pronounced tubulointerstitial and mild vascular injury
had no impact on renal function in young allografts.
In contrast, renal allograft function further declined in
recipients of old allografts with severe acute allograft
vasculopathy. Furthermore, the induction of LOX-1 and
generation of HOCl-modified epitopes accompanied by
expression of atherogenic adhesion molecule VCAM-1
and transmural inflammatory infiltrates together with an
increased in situ superoxide anion radical production
is corroborative evidence that mechanisms involved in
early atherogenesis may be responsible for the initiation
of age-related early allograft vascular injury, independent
of recipient age. We believe these findings may be clin-
ically relevant. Furthermore, efforts to define molecular
and structural basis of normal human renal ageing are
in progress [20]. Molecular mechanisms involved in cell
senescence in general contribute to the phenotype of re-
nal senescence in F344 rat native kidneys [21] that served
as the donor strain in our experimental model. Addition-
ally, markers of cellular senescence were highly expressed
in tubular epithelia of ischemically damaged or chroni-
cally rejected kidneys of rats with young age in a recent
study employing F344 to Lew rat renal transplantation
model [22]. While tubular pathology remained in the fo-
cus of these investigations, we were rather interested in
evolution of transplant vascular changes as they are even
more critical to the outcome.
Compared to tubulointerstitial rejections, vascular re-
jections are associated with significantly worse trans-
plant outcome in the short- and long-term [23]. Diagno-
sis of chronic allograft nephropathy in combination with
transplant vasculopathy (cv-score ≥1), implied a poorer
allograft survival than chronic allograft nephropathy
without vascular involvement in a study employing 3-
month posttransplant protocol biopsies [24]. Progressive
hyalinosis of preglomerular vessels and glomerular scle-
rosis are common features after the first year posttrans-
plant [25]. We believe that the initial events preceding
activation of effector processes and resulting in transplant
vasculopathy may operate in a very narrow time-window
that starts during the immediate postreperfusion period.
Old allografts had increased superoxide anion produc-
tion despite milder intragraft inflammation suggesting
age-related decreased oxidant scavenging capacity. In-
formation on early events in human transplants is insuf-
ficient as protocol core needle biopsies are not routinely
performed during the first posttransplant week [25] and
results derived either from implantation or immediate
postreperfusion biopsies usually reflect preexisting donor
pathology [26]. Our well-established life-supporting low-
allogeneic F344-to-Lew rat model allowed us to study iso-
lated effect of age on early allograft injury. Unlike aged
human donors, aged F344 donor rats are mammals with
normal serum lipid profiles that do not exhibit preexist-
ing vascular injury in terms of fibrous intimal thickening.
Thus, features of vascular pathology we documented in
the present study reflect isolated age-related response to
transplant injury independent of hyperlipidemia.
We suggest that an increase in intravascular superox-
ide anion radical production that we observed during
the early postreperfusion period instigated the cascade
of events involving LOX-1 and HOCl-modified lipopro-
teins. Increased transcription of LOX-1 was observed as
early as 12 hours after reperfusion in ischemia reflow
model in native rat kidneys [27]. Superoxide anion radical
and its dismutation product, H2O2, serve as potent stim-
uli for recruitment of inflammatory cells such are neu-
trophil granulocytes and monocytes, the predominant in
vivo sources for MPO. The ability of MPO to generate
HOCl is a unique and defining activity for this enzyme in
particular in the kidney [10].
The overall vascular wall staining patterns of HOCl-
modified lipoproteins observed in rat renal transplant ar-
terial lesions in our study was similar to those observed in
human [16, 28] and rabbit atherosclerotic lesions [29]. We
employed antibodies specific for hypochlorite-modified
LDL epitopes that directly indicate HOCl production in
vivo [16]. HOCl-mediated LDL/protein oxidation occurs
during the earliest stages of atherogenesis [28]. A recent
study revealed that HOCl-LDL contributes to endothe-
lial dysfunction via intracellular dislocalization of the en-
dothelial nitric oxide synthase and impaired nitric oxide
synthesis in endothelial cells [12]. In human renal pathol-
ogy, HOCl-modified epitopes are present in tubulointer-
stitial nephritis and benign nephrosclerosis [30] as well
as in glomeruli of patients with membranous nephropa-
thy [31]. Furthermore, oxidized LDL is increasingly
recognized as important in renal diseases [32]. In proto-
col renal transplant biopsies the interstitial accumulation
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Fig. 3. The effect of allograft age on interstitial and intravascular infiltration with ED-1+ monocytes/macrophages, CD8+ lymphocytes (% of renal
cortical and medullary tissue positive for ED-1 and CD8 or% of ED-1+ or CD8+ intravascular immunostained area in relation to total arterial cross
sectional area), and arterial expression of vascular cell adhesion molecule (VCAM) (shown as% of all arteries). Allograft age increased ED-1+
interstitial infiltration (A), but not CD8+ infiltration (B). Allograft age increased ED-1+ (C) and CD8+ (D) intravascular infiltration independent
of recipient age. Lack of age effects on percentage of VCAM-1–positive arteries (E) are evident. Data as means ±SD. ∗P ≤ 0.05; ∗∗P ≤ 0.005 versus
young transplants (N = 5/time point).
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FE
Fig. 4. The renal allograft vascular pathol-
ogy (representative of four grafts/per time
point, hematoxylin and eosin) at 7 and 10 days.
Activated endothelial cells in arterial section
from young allograft 7 days posttransplant
(A), activated endothelial cells, mononuclear
cell margination and subendothelial mononu-
clear cells in old allograft transplanted to old
recipient (C), and old allograft transplanted
to young recipient (E) 7 days posttransplant,
mononuclear cell attachment to activated en-
dothelia in artery from young allograft 10 days
posttransplant (B), transmural arteritis with
focal fibrinoid necrosis (arrowhead) in old al-
lografts of old recipients 10 days posttrans-
plant (D), and transmural arteritis in old allo-
grafts of young donors 10 days posttransplant
(F).
of oxidized LDL was associated with the presence of
macrophages and a higher fractional interstitial volume
at 1 12 years [33]. Although, that study focused on tubu-
lointerstitial changes, the positive endothelial staining for
LDL and oxidized LDL was observed in arterial intima
[33]. Effects of oxidized LDL on endothelial cells dur-
ing formation of atherosclerotic lesions are mediated by
LOX-1 [9]. Activation of endothelial cells by HOCl-LDL
could lead to the upregulation of VCAM-1 at later time
points that further facilitates infiltration of macrophages
and lymphocytes thereby worsening vascular injury. In
human proximal tubular cells up-regulation of VCAM-1
after stimulation with HOCl-LDL was recently described
[34].
Similar to our findings, increased VCAM-1 expres-
sion on renovascular endothelium was observed in as-
sociation with CD3+ infiltrates in rejecting human renal
allografts [35]. In cardiac allografts, the medial smooth
muscle cells of injured coronary arteries express VCAM-
1 accompanied with expression of foreign major histo-
compatability complex (MHC) antigens [36]. Compared
to atherosclerosis in native organs, transplant vasculopa-
thy in particular in heart is usually accelerated in the
face of alloantigen-mediated specific immune response
operated through cytotoxic lymphocytes of complement
fixing alloantibodies [6]. We observed overexpression
of VCAM-1 on endothelium and affection of vascular
smooth muscle cells in relation to the length of cold
preservation in our earlier study [37]. Along this line,
cold ischemic injury and alloantigen stimulation in syn-
ergy facilitated earlier onset and severity of chronic
vasculopathy in renal allografts [38]. Clearly, similar
pathologic features may reflect limited repertoire of re-
nal vascular response to different injurious stimuli such
as hypertension, hyperlipidemia, or hyperglycaemia. We
excluded all these possible confounders in our model. In
addition we attempted to block a possible direct alloanti-
genecity effect with continuous CyA administration. This
treatment decreased interstitial infiltrates, but had no ef-
fect on vasculopathy or LOX-1 expression. We suggest
that advanced age of the recipient represents a state of
an increased oxidative stress [5] targeting in particular
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Fig. 5. Percentage of lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1)–positive arteries 7 and 10 days posttransplant and
localization of arterial LOX-1 10 days posttransplant. (A) Increased number of LOX-1–positive arteries in old allografts independent of recipient age
at day 7 posttransplant. Mean ±SD. ∗P ≤ 0.05 versus young transplants. (B) In young allografts LOX-1 expression was restricted to the endothelium.
(C) In old allografts transplanted to old recipients both endothelium and muscular layer were positive for LOX-1. (D) Similar LOX-1 staining
pattern affecting both endothelium and muscular layer in old allografts transplanted to young recipients (diaminobenzidine peroxidase) [original
magnification ×20 in (B and D) and ×40 in (C)].
aged donor vessels with a decreased oxygen radical scav-
enging capacity. Young recipients have more active innate
immune responses in terms of inflammatory cell recruit-
ment that may act detrimental in the context of impaired
antioxidant defense of the older donor. However, we are
aware of the descriptive limitation of our study and that
the associations we observed do not necessarily provide a
causal relationship between mediators of oxidative stress
and acute transplant vascular injury in aged transplants.
Although, the separate influence of donor age or re-
cipient age on long-term renal allograft survival was al-
ready analyzed in F344-Lew model of chronic allograft
nephropathy [39, 40] and clinical studies [41, 42], infor-
mation on early events is scarce. We tested our hypoth-
esis in age-matched and age-mismatched combinations.
Despite negative effects of older donor age on graft func-
tion and survival, utilization of aged marginal donors re-
mains one of the solutions to match an increasing or-
gan demand. In parallel, age matching is becoming an in-
creasingly accepted issue in allocation of renal transplants
[42]. Eurotransplant has recently established a senior al-
location program that allows “compromised recipients”
≥65 years of age to receive a kidney from the “marginal
donor” of the same age [43]. First studies implicate
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Fig. 6. Intravascular colocalization. (A) Lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1) colocalizes (B) in serial sections
with hypochlorous acid/hypochlorite (HOCl)-modified epitopes. (C) In old allografts 10 days posttransplant, transmural inflammatory infiltrate was
primarily composed of ED-1+ macrophages (D) and scattered CD8+ lymphocytes (diaminobenzidine peroxidase) [original magnification ×40 in
(A, B, and D) and ×20 in (C)].
A B C
Fig. 7. Cyclosporine A (CyA) exerts no effect on vascular injury (A), lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1)
expression in old animals at day 7 post-transplant (B) compared to nontreated age-matched control (C).
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Fig. 8. In situ superoxide anion production in
age-matched and age-mismatched allografts
7 and 10 days posttransplant. (A) Increased
number of dehydroethidium (DHE)-positive
fluorescent nuclei in old allografts indepen-
dent of recipient age at day 7 and 10 posttrans-
plant. Means ±SD. ∗P ≤ 0.05 versus young
transplants (N = 5/time point). (B) DHE
fluorescence in young allografts. (C) Old al-
lografts transplanted to old recipients. (D)
Old allografts transplanted to young recipi-
ents 7 days posttransplant (original magnifi-
cation ×40).
successful expansion of donor and recipient pool without
affecting patient and graft survival [43, 44]. We believe
that our experimental findings have relevance for alloca-
tion policy. The benefit of receiving a marginal transplant
may be limited for a young recipient. An involvement of
LOX-1 pathway seems logical in light of current under-
standing of the pathophysiology of aging and analogies
with atherosclerotic processes. Elucidation of risks as-
sociated with ageing may improve diagnostic and thera-
peutic strategies. Considering difficulties associated with
immunosuppression in the elderly [45], attention should
be given to strategies that confer antioxidative protec-
tion and thereby may exert pleiotropic immunodulatory
effects. Since LOX-1 expression can be induced by an-
giotensin II [46], angiotensin-converting enzyme inhibi-
tion or angiotensin II type 1 receptor blockade may offer
a promising strategy in this setting. We aim to address this
issue in our forthcoming studies.
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